Research is proposed which will further investigate the basis for behavioral/motor recovery following striatal dopamine (DA) depletion in cats administered the toxin MPTP. Previous work showed that motor recovery occurs in previously parkinsonian cats despite no significant recovery of tissue levels of DA in the dorsal striatum. Pilot studies using microdialysis though have shown that recovered cats have significantly recovered dorsal striatal extracellular fluid (ECF) DA levels which is not reflected in the tissue neurochemistry. Since post mortem neurochemistry does not seem to reflect the functional integrity of the striatum in recovered cats, in vivo microdialysis experiments are proposed to study whether there is a causal relationship between ECF DA neurochemistry, motor deficits, and functional recovery. Since ECF DA is recovered in the dorsal striatum despite a 95% depletion of tissue DA in this region, where does this DA come from? We will test hypotheses that ECF DA in dorsal striatum in recovered cats either originates in less denervated ventral striatal regions and via enhanced diffusion due to loss of DA reuptake sites reaches the dorsal striatum or that the dorsal striatal DA originates in endogenous terminals spared by the lesion or by a terminal sprouting response into the dorsal striatum. Quantitative autoradiographic studies of pre-and post-synaptic mechanisms in the striatum (i.i., DA reuptake sites/terminal density, DA D1 and D2 and serotonin 5-HT2 receptor densities) will provide additional information concerning the functional status of striatal sub-regions in normal, symptomatic, and recovered cats. This information, together with microdialysis data, should provide a more detailed understanding of functional striatal neurochemistry than previously obtained and should provide new information relevant to understanding the mechanisms underlying DA-related motor deficits and the nature of the ensuing recovery process. A second goal of the proposed research is study the functional role of DA in the striatum and its influence on sensorimotor integration and motor behavior by examining response properties of physiologically defined populations of striatal neurons during the performance of a learned motor response in normal, motor impaired, and motor recovered animals. Previous data suggests the attenuation of striatal sensory responsiveness during MPTP parkinsonism may be due to a disruption of sensory processing afferent to the striatum. This new hypothesis will be tested by examining sensory response properties of intralaminar thalamic neurons in normal, motor impaired, and recovered cats. These studies should provide new information concerning the possible mechanisms underlying sensorimotor impairment due to DA depletion and the nature of compensatory mechanisms which may lead to behavioral/motor recovery. These studies may have relevance for understanding pathophysiological mechanisms relevant to Parkinson's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS023980-06
Application #
2265039
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1988-07-01
Project End
1995-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Neurology
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Wade, Timothy V; Schneider, Jay S (2004) Striatal preprotachykinin gene expression reflects parkinsonian signs. Neuroreport 15:2481-4
Schroeder, Joseph A; Schneider, Jay S (2002) GABA(A) and mu-opioid receptor binding in the globus pallidus and endopeduncular nucleus of animals symptomatic for and recovered from experimental Parkinsonism. Brain Res 947:284-9
Schroeder, J A; Schneider, J S (2002) GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion. J Neurochem 82:666-73
Rothblat, D S; Schroeder, J A; Schneider, J S (2001) Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism. J Neurosci Res 65:254-66
Schroeder, J A; Schneider, J S (2001) Alterations in expression of messenger RNAs encoding two isoforms of glutamic acid decarboxylase in the globus pallidus and entopeduncular nucleus in animals symptomatic for and recovered from experimental Parkinsonism. Brain Res 888:180-183
Wade, T V; Rothblat, D S; Schneider, J S (2001) Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism. Brain Res 905:111-9
Wade, T; Rothblat, D S; Schneider, J S (2000) Changes in striatal dopamine D(2) receptors in relation to expression of and recovery from experimental parkinsonism. Brain Res 871:281-7
Schroeder, J A; Schneider, J S (2000) Striatal enkephalin gene expression does not reflect parkinsonian signs. Neuroreport 11:1799-802
Rothblat, D S; Schneider, J S (1999) Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study. J Neurochem 72:724-33
Schneider, J S; Schroeder, J A; Rothblat, D S (1998) Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation. Brain Res 813:82-7

Showing the most recent 10 out of 23 publications